Literature DB >> 14612599

Serous effusions: diagnosis of malignancy beyond cytomorphology. An analytic review.

S K Mohanty1, P Dey.   

Abstract

In this brief review, the role of various ancillary techniques to detect malignancy in effusion fluid are evaluated and discussed. The data were collected from a large number of research articles published in various medical journals. The role of these techniques to increase the diagnostic accuracy in serous effusions is emphasised.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14612599      PMCID： PMC1742845          DOI： 10.1136/pmj.79.936.569

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  99 in total

Review 1.  The prognostic importance of tumor markers in adenocarcinomas of the gastrointestinal tract.

Authors:  J Grem
Journal:  Curr Opin Oncol       Date:  1997-07       Impact factor: 3.645

2.  Flow cytometry in diagnostic cytology.

Authors:  T J O'Leary
Journal:  Diagn Cytopathol       Date:  1998-01       Impact factor: 1.582

3.  Utility of the antibodies CA 19-9, HBME-1, and thrombomodulin in the diagnosis of malignant mesothelioma and adenocarcinoma in cytology.

Authors:  P A Fetsch; A Abati; Y M Hijazi
Journal:  Cancer       Date:  1998-04-25       Impact factor: 6.860

Review 4.  MIB-1 (Ki-67) immunostaining of breast cancer cells in cytologic smears.

Authors:  P Dalquen; B Baschiera; R Chaffard; H Dieterich; G E Feichter; K Krmer; J Torhorst
Journal:  Acta Cytol       Date:  1997 Mar-Apr       Impact factor: 2.319

5.  Telomerase activity in pleural effusions: diagnostic significance.

Authors:  C T Yang; M H Lee; R S Lan; J K Chen
Journal:  J Clin Oncol       Date:  1998-02       Impact factor: 44.544

6.  HBME-1 and antithrombomodulin in the differential diagnosis of malignant mesothelioma of pleura.

Authors:  A D Kennedy; G King; K M Kerr
Journal:  J Clin Pathol       Date:  1997-10       Impact factor: 3.411

7.  E-cadherin and calretinin: a useful combination of immunochemical markers for differentiation between mesothelioma and metastatic adenocarcinoma.

Authors:  M P Leers; M M Aarts; P H Theunissen
Journal:  Histopathology       Date:  1998-03       Impact factor: 5.087

8.  Telomerase activation in cervical cancer.

Authors:  S Anderson; K Shera; J Ihle; L Billman; B Goff; B Greer; H Tamimi; J McDougall; A Klingelhutz
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

9.  Cancer of the uterine cervix: sensitivity and specificity of serum Cyfra 21.1 determinations.

Authors:  N Callet; C C Cohen-Solal Le Nir; E Berthelot; M F Pichon
Journal:  Eur J Gynaecol Oncol       Date:  1998       Impact factor: 0.196

10.  Evaluation of pleural CYFRA 21-1 and carcinoembryonic antigen in the diagnosis of malignant pleural effusions.

Authors:  G Salama; M Miédougé; P Rouzaud; M A Mauduyt; M C Pujazon; C Vincent; P Carles; G Serre
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640
View more
  7 in total

1.  Diagnostic value of acid phosphatases (ACP) in differentiating reactive mesothelial cells from cancer cells in the body fluid effusions.

Authors:  Yun-Hui Li; Yang Wang; Xiu-Xia Chen; Bin Liang; Xue-Shan Qiu; En-Hua Wang; Guang-Ping Wu
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

2.  Use of Panel of Markers in Serous Effusion to Distinguish Reactive Mesothelial Cells from Adenocarcinoma.

Authors:  Devi Subbarayan; Jenna Bhattacharya; Poonam Rani; Bembem Khuraijam; Shyama Jain
Journal:  J Cytol       Date:  2019 Jan-Mar       Impact factor: 1.000

3.  Detection of EpCAM-positive microparticles in pleural fluid: A new approach to mini-invasively identify patients with malignant pleural effusions.

Authors:  Elisa Roca; Romaric Lacroix; Coralie Judicone; Sophie Laroumagne; Stéphane Robert; Sylvie Cointe; Alexandre Muller; Elise Kaspi; Patrice Roll; Alain R Brisson; Claudio Tantucci; Philippe Astoul; Françoise Dignat-George
Journal:  Oncotarget       Date:  2016-01-19

Review 4.  Flow cytometry, molecular analysis, and other special techniques (in Serous Fluid Cytopathology).

Authors:  Ali Gabali
Journal:  Cytojournal       Date:  2022-03-19       Impact factor: 2.345

5.  Diagnostic Utility of Combined CEA, CA15-3 and CA125 Biomarkers and Cytomorphology in Suspicious and Malignant Serosal Fluid.

Authors:  Zahra Rahemi; Abdolreza Javadi; Behrang Kazeminejad; Abdolali Ebrahimi; Houman Vosough; Afsoon Taghavi; Shahriar Dabiri
Journal:  Iran J Pathol       Date:  2021-05-09

6.  Validating Micronucleus Score in Effusion Fluids.

Authors:  Nidhya Ganesan; Manjiri D Phansalkar; Marie M Ambroise; Renu G Varghese
Journal:  J Cytol       Date:  2017 Oct-Dec       Impact factor: 1.000

7.  Micronucleus and Its Significance in Effusion Fluids.

Authors:  Dravya Jayakumar; Kalpana Kumari Kasturi
Journal:  J Cytol       Date:  2019-12-23       Impact factor: 1.000
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.